TOKYO, July 22, 2026
Kirin Holdings Company, Limited and Blackmores Limited have announced the launch of two new Cognizin® Citicoline-based cognitive support supplements designed to promote memory, attention, focus, mental clarity, and overall brain health across Australia and New Zealand. The products—Blackmores Cognition Ultra in Australia and Blackmores Ultra Brain Care in New Zealand—will begin a phased rollout in late July 2026, representing the first Blackmores cognitive performance supplement developed since the company’s integration into the Kirin Group. Powered by Cognizin® Citicoline, a clinically studied branded ingredient developed by Kyowa Hakko Bio, the new supplements highlight Kirin’s continued investment in health science innovation and evidence-based nutritional solutions. The launch combines Blackmores’ trusted consumer health expertise with Kyowa Hakko Bio’s biotechnology and fermentation capabilities, reinforcing the group’s strategy to deliver science-backed wellness products addressing growing consumer demand for healthy cognitive ageing and long-term brain performance.
Science-Backed Cognitive Nutrition Targets Brain Performance
The newly introduced supplements feature 250 mg of Cognizin® Citicoline per tablet, with a recommended daily intake of two tablets or as advised by healthcare professionals. Cognizin® Citicoline is a clinically validated and patented form of citicoline, produced through advanced fermentation biotechnology developed by Kyowa Hakko Bio. Scientific studies have associated the ingredient with supporting memory recall, attention, information processing, mental focus, and overall cognitive performance while remaining caffeine-free, making it suitable for everyday cognitive support. According to Kirin and Blackmores, increasing awareness of age-related cognitive decline, workplace productivity, and lifelong brain wellness has significantly expanded consumer interest in nutritional products designed to support healthy brain function. By combining clinically researched ingredients with high-quality manufacturing, the companies aim to provide consumers with reliable nutritional support for maintaining mental performance throughout adulthood.
Regional Launch Reflects Kirin’s Health Science Strategy
The launch represents another milestone in the strategic collaboration established after Blackmores joined the Kirin Group in August 2023. Since the acquisition, both companies have focused on integrating consumer health expertise, scientific innovation, and biotechnology research to address evolving health needs across the Asia-Pacific region. Blackmores Cognition Ultra will initially be available through Blackmores’ official e-commerce platform in Australia before expanding into pharmacy distribution in September 2026. Meanwhile, Blackmores Ultra Brain Care will launch through pharmacy channels across New Zealand beginning in late July. Both products share the same formulation while featuring market-specific labeling to comply with local regulatory requirements. The supplements are manufactured at Blackmores’ Braeside production facility, ensuring quality standards aligned with the company’s long-standing reputation in nutritional health products.
Advertisement
Regulatory Recognition Supports Consumer Brain Health Innovation
The launch also follows an important regulatory milestone, with Cognizin® Citicoline recognized as a new ingredient by Australia’s Therapeutic Goods Administration (TGA), supporting its inclusion in evidence-based nutritional formulations. The products are positioned to support brain health, memory, mental clarity, attention, and focus, with product claims tailored to meet each country’s regulatory framework. The initiative further strengthens Kirin Group’s Health Science portfolio, demonstrating how advanced biotechnology and clinically supported ingredients can be translated into consumer wellness solutions. As demand continues to rise for scientifically validated cognitive health products, Blackmores and Kyowa Hakko Bio aim to expand access to innovative nutritional supplements that promote healthy ageing and long-term cognitive wellbeing. The launch underscores the companies’ commitment to combining scientific research, fermentation technology, and nutrition innovation to help consumers maintain optimal brain performance throughout life.
Source: Kyowa Hakko, Cognizin press release
